Irish drug developer signs licensing deal for autoimmune therapies
Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Inflection Biosciences
Irish company Inflection sells cancer drug to Singapore group
Dublin pharma development company’s drug blocks pathways used by cancer cells
Irish drug company signs research deal with Texas university
Inflection Biosciences working on new way to block spread of cancer cells in patients
Builders warn of skills shortage, Government’s climate credentials and Cairn sells €25m in new houses
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Dublin company Inflection Biosciences signs research deal with Trinity College
Start-up working on way to block spread of cancer cells in patients with aggressive breast cancer
Irish company to showcase ‘breakthrough’ breast cancer drug
Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices